Evaluation of Single Versus Two‐Dose Basiliximab Induction Therapy in Live‐Donor Liver Transplant
Clinical Transplantation · 2024
DOI: 10.1111/ctr.70006 ↗At a glance
Vergleichsstudie in Clinical Transplantation, 2024. Written by Benjamin N Herrmann and 4 co-authors. Institution: Department of Pharmacy, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA. Major MEDLINE topics: Basiliximab, Liver Transplantation, Recombinant Fusion Proteins, Graft Rejection. Cited 3 times so far (Crossref); 26 references.
Abstract (original language)
Background
Basiliximab is a high‐cost induction agent typically given as two doses in liver transplant recipients. This study evaluated renal outcomes in live‐donor liver transplant recipients (LDLTRs) with stable renal function at the time of transplant receiving one versus two doses of basiliximab.
Methods
We retrospectively identified 231 adult LDLTR with a serum creatinine (SCr)
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pharmacy, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
- Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy, Pittsburgh, Pennsylvania, USA.
- Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
ORCID profiles: Benjamin N Herrmann
Cite
APA
Herrmann, B. N., Moore, C. A., Johnson, H. J., Humar, A., & Shimko, K. A. (2024). Evaluation of Single Versus Two‐Dose Basiliximab Induction Therapy in Live‐Donor Liver Transplant. Clinical Transplantation. https://doi.org/10.1111/ctr.70006
Vancouver
Herrmann BN, Moore CA, Johnson HJ, Humar A, Shimko KA. Evaluation of Single Versus Two‐Dose Basiliximab Induction Therapy in Live‐Donor Liver Transplant. Clinical Transplantation. 2024. doi:10.1111/ctr.70006
BibTeX
@article{Herrmann2024,
author = {Herrmann, Benjamin N and Moore, Cody A and Johnson, Heather J and Humar, Abhinav and Shimko, Kristen A},
title = {Evaluation of Single Versus Two‐Dose Basiliximab Induction Therapy in Live‐Donor Liver Transplant},
journal = {Clinical Transplantation},
year = {2024},
doi = {10.1111/ctr.70006}
}
EUVIMED